Heat-shock protein peptide complex–96 vaccination for recurrent glioblastoma: a phase II, single-arm trial

BACKGROUND: Outcomes for patients with recurrent glioblastoma multiforme (GBM) are poor and may be improved by immunotherapy. We investigated the safety and efficacy of an autologous heat-shock protein peptide complex–96 (HSPPC-96) vaccine for patients with recurrent GBM. METHODS: In this open-label...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bloch, Orin, Crane, Courtney A., Fuks, Yelena, Kaur, Rajwant, Aghi, Manish K., Berger, Mitchel S., Butowski, Nicholas A., Chang, Susan M., Clarke, Jennifer L., McDermott, Michael W., Prados, Michael D., Sloan, Andrew E., Bruce, Jeffrey N., Parsa, Andrew T.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3895386/
https://ncbi.nlm.nih.gov/pubmed/24335700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/not203
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados